Three-Year Safety and Efficacy of Eylea™ 8 mg for Diabetic Macular Edema
Bayer and Regeneron presented the three-year results from the open-label extension of the PHOTON clinical trial on diabetic macular edema (DME) at the American Academy of Ophthalmology Annual Meeting, held October 18-21 in Chicago. The study showed that patients initially…